Teladoc Health, Inc. (0LDR.L)
USD 7.07
(1.02%)
USD 7.07
(1.02%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -220.36 Million USD | 98.39% |
| 2022 | -13.65 Billion USD | -3085.58% |
| 2021 | -428.79 Million USD | 11.61% |
| 2020 | -485.13 Million USD | -390.71% |
| 2019 | -98.86 Million USD | -1.83% |
| 2018 | -97.08 Million USD | 9.08% |
| 2017 | -106.78 Million USD | -43.88% |
| 2016 | -74.21 Million USD | -27.91% |
| 2015 | -58.02 Million USD | -240.55% |
| 2014 | -17.03 Million USD | -183.05% |
| 2013 | -6.01 Million USD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -837.67 Million USD | -922.93% |
| 2024 Q3 | -33.27 Million USD | 96.03% |
| 2024 Q1 | -81.88 Million USD | -183.45% |
| 2023 Q1 | -69.22 Million USD | 98.18% |
| 2023 Q3 | -57.07 Million USD | 12.43% |
| 2023 Q2 | -65.17 Million USD | 5.85% |
| 2023 FY | -220.36 Million USD | 98.39% |
| 2023 Q4 | -28.89 Million USD | 49.38% |
| 2022 Q3 | -73.47 Million USD | 97.63% |
| 2022 Q1 | -6.67 Billion USD | -60660.34% |
| 2022 FY | -13.65 Billion USD | -3085.58% |
| 2022 Q4 | -3.81 Billion USD | -5085.46% |
| 2022 Q2 | -3.1 Billion USD | 53.53% |
| 2021 FY | -428.79 Million USD | 11.61% |
| 2021 Q2 | -133.81 Million USD | 32.97% |
| 2021 Q3 | -84.34 Million USD | 36.97% |
| 2021 Q4 | -10.98 Million USD | 86.98% |
| 2021 Q1 | -199.64 Million USD | 49.32% |
| 2020 FY | -485.13 Million USD | -390.71% |
| 2020 Q4 | -393.96 Million USD | -997.89% |
| 2020 Q3 | -35.88 Million USD | -39.72% |
| 2020 Q2 | -25.68 Million USD | 13.25% |
| 2020 Q1 | -29.6 Million USD | -55.45% |
| 2019 Q4 | -19.04 Million USD | 6.4% |
| 2019 Q2 | -29.32 Million USD | 2.74% |
| 2019 FY | -98.86 Million USD | -1.83% |
| 2019 Q1 | -30.15 Million USD | -21.19% |
| 2019 Q3 | -20.34 Million USD | 30.62% |
| 2018 Q4 | -24.87 Million USD | -6.94% |
| 2018 Q2 | -25.07 Million USD | -5.1% |
| 2018 Q3 | -23.26 Million USD | 7.24% |
| 2018 FY | -97.08 Million USD | 9.08% |
| 2018 Q1 | -23.86 Million USD | 46.24% |
| 2017 Q3 | -31.33 Million USD | -103.24% |
| 2017 Q1 | -15.65 Million USD | -9.77% |
| 2017 FY | -106.78 Million USD | -43.88% |
| 2017 Q2 | -15.41 Million USD | 1.53% |
| 2017 Q4 | -44.38 Million USD | -41.66% |
| 2016 Q1 | -15.3 Million USD | -1.98% |
| 2016 FY | -74.21 Million USD | -27.91% |
| 2016 Q4 | -14.26 Million USD | 52.1% |
| 2016 Q3 | -29.77 Million USD | -100.09% |
| 2016 Q2 | -14.87 Million USD | 2.78% |
| 2015 Q4 | -15 Million USD | -13.29% |
| 2015 Q2 | -17.06 Million USD | -34.33% |
| 2015 Q1 | -12.7 Million USD | -81.65% |
| 2015 Q3 | -13.24 Million USD | 22.37% |
| 2015 FY | -58.02 Million USD | -240.55% |
| 2014 Q2 | -3.2 Million USD | -38.29% |
| 2014 Q4 | -6.99 Million USD | -54.4% |
| 2014 Q1 | -2.31 Million USD | 0.0% |
| 2014 FY | -17.03 Million USD | -183.05% |
| 2014 Q3 | -4.52 Million USD | -41.53% |
| 2013 FY | -6.01 Million USD | 0.0% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Phreesia, Inc. | -136.88 Million USD | -60.988% |
| Accuray Incorporated | -15.54 Million USD | -1317.613% |
| Align Technology, Inc. | 445.05 Million USD | 149.515% |
| Elevance Health Inc. | 5.98 Billion USD | 103.681% |
| AxoGen, Inc. | -21.71 Million USD | -914.773% |
| Boston Scientific Corporation | 1.59 Billion USD | 113.834% |
| CVS Health Corporation | 8.34 Billion USD | 102.641% |
| Cardinal Health, Inc. | 852 Million USD | 125.865% |
| Centene Corporation | 2.7 Billion USD | 108.156% |
| DaVita Inc. | 691.53 Million USD | 131.866% |
| HCA Healthcare, Inc. | 5.24 Billion USD | 104.204% |
| Hologic, Inc. | 789.5 Million USD | 127.912% |
| Humana Inc. | 2.48 Billion USD | 108.854% |
| IDEXX Laboratories, Inc. | 845.04 Million USD | 126.078% |
| Laboratory Corporation of America Holdings | 418 Million USD | 152.72% |
| Masimo Corporation | 81.5 Million USD | 370.39% |
| McKesson Corporation | 3 Billion USD | 107.341% |
| Patterson Companies, Inc. | 185.93 Million USD | 218.521% |
| Quest Diagnostics Incorporated | 854 Million USD | 125.804% |
| ResMed Inc. | 1.02 Billion USD | 121.585% |
| Henry Schein, Inc. | 416 Million USD | 152.973% |
| Universal Health Services, Inc. | 717.79 Million USD | 130.701% |
| Veeva Systems Inc. | 525.7 Million USD | 141.919% |
| Baxter International Inc. | 2.65 Billion USD | 108.297% |
| Becton, Dickinson and Company | 1.48 Billion USD | 114.85% |
| Intuitive Surgical, Inc. | 1.79 Billion USD | 112.256% |
| Danaher Corporation | 4.2 Billion USD | 105.247% |
| Stryker Corporation | 3.16 Billion USD | 106.963% |
| Medtronic plc | 3.67 Billion USD | 105.995% |